Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Biomed Pharmacother Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes
139,140 In addition, recently, IDH1 and IDH2 gene mutations have been prevalent in several diverse malignancies, including glioma, AML, angioimmunoblastic lymphomas, chondrosarcoma, and melanomas
Lifelong treatment with antioxidants has been recommended in an attempt to prevent morbidity and mortality associated with the disorder
Batch: GF-GHK50-B242 Key analytical results include: Assay Content: 50.7 mg Identification Retention Time: 0.994 Identification Spectrum: 1000 Purity: greater than 99.8 percent Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Product Overview GHK-Cu is a copper-binding synthetic peptide complex studied in controlled laboratory environments focused on peptide-mediated signalling pathways and molecular regulatory systems
PMID 10064598
The mechanisms involved in different studies are different or complicated, some of the experimental results are controversial and contradictory, and lack of systematic summary
